ACADIA Pharmaceuticals
ACAD
$15.21
Share price
-11.21%
Change (1 day)
-29.02%
Change (1 year)
Categories
ACADIA Pharmaceuticals (ACAD) - P/B ratio
P/B ratio as of May 2024 : 5.82
According to ACADIA Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 5.82.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
ACADIA Pharmaceuticals - P/B ratio (from 2004 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 11.9 | 84.93% |
| 2022-12-31 | 6.44 | -7.19% |
| 2021-12-31 | 6.94 | -48.82% |
| 2020-12-31 | 13.6 | 42.66% |
| 2019-12-31 | 9.50 | 95.69% |
| 2018-12-31 | 4.86 | -56.47% |
| 2017-12-31 | 11.2 | 65.55% |
| 2016-12-31 | 6.74 | -62.96% |
| 2015-12-31 | 18.2 | 77.25% |
| 2014-12-31 | 10.3 | -17.89% |
| 2013-12-31 | 12.5 | 211.52% |
| 2012-12-31 | 4.01 | 64.39% |
| 2011-12-31 | 2.44 | 53.46% |
| 2010-12-31 | 1.59 | -61.92% |
| 2009-12-31 | 4.18 | 561.5% |
| 2008-12-31 | 0.6314 | -82.45% |
| 2007-12-31 | 3.60 | -8.17% |
| 2006-12-31 | 3.92 | -7.02% |
| 2005-12-31 | 4.21 | 13.38% |
| 2004-12-31 | 3.72 | |
| 2003-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.15 | -11.50% | 🇺🇸 USA |
 Pfizer PFE | 1.79 | -69.27% | 🇺🇸 USA |
 Eli Lilly LLY | 56.9 | 876.93% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 5.48 | -5.83% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | 0.5351 | -90.81% | 🇺🇸 USA |